New quantitative trait loci that contribute to cholesterol gallstone formation detected in an intercross of CAST/Ei and 129S1/SvImJ inbred mice

Physiological Genomics

Volumn 14, Issue , 2003, Pages 225-239

  Lyons, Malcolm A ^a   Wittenburg, Henning ^a,b   Li, Renhua ^a   Walsh, Kenneth A ^a   Leonard, Monika R ^b   Churchill, Gary A ^a   Carey, Martin C ^b   Paigen, Beverly ^a  

^a JACKSON LABORATORY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Castaneus; Cebpb; Cholelithiasis; Genetics; Lith genes; Mouse; Pparg; Slc21a1

Indexed keywords

CHOLESTEROL; CELL RECEPTOR; LIPID; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEBPB GENE; CHOLELITHIASIS; CHOLESTEROL DIET; CHOLESTEROL STONE; CHOLESTEROL TRANSPORT; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 16; CHROMOSOME 2; CHROMOSOME 5; CONTROLLED STUDY; CROSS BREEDING; ENVIRONMENTAL FACTOR; GALLSTONE; GENE; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; INBRED STRAIN; LINKAGE ANALYSIS; LITH GENE; LITH12 GENE; LITH13 GENE; LITH14 GENE; LITH6 GENE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHENOTYPE; PPARG GENE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SLC21A1 GENE; STATISTICAL ANALYSIS; STONE FORMATION; STRAIN DIFFERENCE; ALLELE; ANIMAL; BILE; CHEMISTRY; CHROMOSOME MAP; DBA MOUSE; FEMALE; GALLBLADDER; GENE EXPRESSION PROFILING; GENETIC LINKAGE; GENETICS; MALE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; PREVALENCE;

ANIMALIA;

ALLELES; ANIMALS; BILE; CHOLELITHIASIS; CHOLESTEROL; CHROMOSOME MAPPING; CROSSES, GENETIC; FEMALE; GALLBLADDER; GENE EXPRESSION PROFILING; LINKAGE (GENETICS); LIPIDS; MALE; MICE; MICE, INBRED DBA; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; PREVALENCE; QUANTITATIVE TRAIT LOCI; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0141798516     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00073.2003     Document Type: Article

References (63)

1. Admirand WH and Small DM. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 47: 1043-1052, 1968.
2. Azer SA and Stacey NH. Current concepts of hepatic uptake, intracellular transport and biliary secretion of bile acids: physiological basis and pathophysiological changes in cholestatic liver dysfunction. J Gastroenterol Hepatol 11: 396-407, 1996.
3. Boelsterli UA and Bedoucha M. Toxicological consequences of altered peroxisome proliferator-activated receptor γ (PPARγ) expression in the liver: insights from models of obesity and type 2 diabetes. Biochem Pharmacol 63: 1-10, 2002.
4. Bouchard G, Chao HC, Lammert F, Wang DQ, Carey MC, and Paigen B. Cmoat is a candidate gene for Lith2, a cholesterol gallstone gene found on chromosome 19 in inbred mice (Abstract). Hepatology 28: 1360, 1998.
5. Bouchard G, Johnson D, Carver T, Carey MC, and Paigen B. Multiple new murine models of cholesterol gallstones (ChGS): The Jackson Laboratory-Brigham and Women's Hospital strain survey (Abstract). Gastroenterology 120: 72, 2001.
6. Bouchard G, Johnson D, Carver T, Paigen B, and Carey MC. Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk. J Lipid Res 43: 1105-1113, 2002.
7. Bray N, Dubchak I, and Pachter L. AVID: a global alignment program. Genome Res 13: 97-102, 2003.
8. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 19: 945-955, 1978.
9. Carey MC and Small DM. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man. J Clin Invest 61: 998-1026, 1978.
10. Churchill GA and Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971, 1994.
11. Cowles CR, Joel NH, Altshuler D, and Lander ES. Detection of regulatory variation in mouse genes. Nat Genet 32: 432-437, 2002.
12. Dam H and Hegardt F. The relation between formation of gallstones rich in cholesterol and the solubility of cholesterol in aqueous solutions of bile salts and lecithin. Z Ernahrungswiss 10: 239-252, 1971.
13. Dansky HM, Shu P, Donavan M, Montagno J, Nagle DL, Smutko JS, Roy N, Whiteing S, Barrios J, McBride TJ, Smith JD, Duyk G, Breslow JL, and Moore KJ. A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. Genetics 160: 1599-1608, 2002.
14. Erlinger S. Bile flow. In: The Liver. Biology and Pathobiology (3rd ed.), edited by Arias IM, Boyer JL, Chisari FV, Fausto N, Schachter D, and Shafritz DA. Philadelphia, PA: Lippincott Williams and Wilkins, 1994, p. 769-786.
15. Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, and Welty TK. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 35: 1507-1512, 2002.
16. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Staels B, Vidal H, and Auwerx J. The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 272: 18779-18789, 1997.
17. Flint J and Mott R. Finding the molecular basis of quantitative traits: successes and pitfalls. Nat Rev Genet 2: 437-445, 2001.
18. Gilat T and Somjen GJ. Phospholipid vesicles and other cholesterol carriers in bile. Biochim Biophys Acta 1286: 95-115, 1996.
19. Hagenbuch B and Meier PJ. The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 1609: 1-18, 2003.
20. Holzbach R, Corbusher C, Marsh M, and Naito H. The process of cholesterol cholelithiasis induced by diet in the prairie dog: a physicochemical characterization. J Lab Clin Med 87: 987-998, 1976.
21. Kao CH, Zeng ZB, and Teasdale RD. Multiple interval mapping for quantitative trait loci. Genetics 152: 1203-1216, 1999.
22. Khanuja B, Cheah YC, Hunt M, Nishina PM, Wang DQH, Chen HW, Billheimer JT, Carey MC, and Paigen B. Lithl, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci USA 92: 7729-7733, 1995.
23. Lammert F, Carey MC, and Paigen B. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map. Gastroenterology 120: 221-238, 2001.
24. Lammert F, Wang DQ, Wittenburg H, Bouchard G, Hillebrandt S, Taenzler B, Carey MC, and Paigen B. Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice. Hepatology 36: 1145-1154, 2002.
25. Lammert F, Wang DQH, Cohen DE, Paigen B, and Carey MC. Functional and genetic studies of biliary cholesterol secretion in inbred mice: evidence for a primary role of sister to P-glycoprotein, the canalicular bile salt export pump, in cholesterol gallstone pathogenesis. In: Falk Symposium 108: Bile Acids and Cholestasis, edited by Paumgartner G, Stiehl A, Keppler D, Gerok W, and Leuschner U. Dordrecht: Kluwer Academic, 1999, p. 224-228.
26. Lander E and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11: 241-247, 1995.
27. Lander ES and Botstein D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121: 185-199, 1989.
28. Lyons MA, Wittenburg H, Li R, Walsh K, Churchill GA, Carey MC, and Paigen B. Quantitative trait loci that determine lipoprotein cholesterol levels in DBA/2J and CAST/Ei inbred mice. J Lipid Res 44: 953-967, 2003.
29. Lyons MA, Wittenburg H, Li R, Walsh K, Leonard MR, Korstanje R, Churchill GA, Carey MC, and Paigen B. Lith6: a new QTL for cholesterol gallstones from an intercross of CAST/Ei and DBA/2J inbred mouse strains. J Lipid Res Jun 16, 2003.
30. Machleder D, Ivandic B, Welch C, Castellani L, Reue K, and Lusis AJ. Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism. J Clin Invest 99: 1406-1419, 1997.
31. Manenti G, Binelli G, Gariboldi M, Canzian F, De Gregorio L, Falvella FS, Dragani TA, and Pierotti MA. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics 23: 118-124, 1994.
32. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, Munch R, Reuter I, Rotert S, Saxel H, Scheer M, Thiele S, and Wingender E. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31: 374-378, 2003.
33. Mayor C, Brudno M, Schwartz JR, Poliakov A, Rubin EM, Frazer KA, Pachter LS, and Dubchak I. VISTA: visualizing global DNA sequence alignments of arbitrary length. Bioinformatics 16: 1046-1047, 2000.
34. Mehrabian M, Castellani LW, Wen PZ, Wong J, Rithaporn T, Hama SY, Hough GP, Johnson D, Albers JJ, Mottino GA, Frank JS, Navab M, Fogelman AM, and Lusis AJ. Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei x C57BL/6J). J Lipid Res 41: 1936-1946, 2000.
35. Mehrabian M, Wong J, Wang X, Jiang Z, Shi W, Fogelman AM, and Lusis AJ. Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia. Circ Res 89: 125-130, 2001.
36. Miller LJ, Holicky EL, Ulrich CD, and Wieben ED. Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology 109: 1375-1380, 1995.
37. Miyake JH, Wang SL, and Davis RA. Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7α-hydroxylase. J Biol Chem 275: 21805-21808, 2000.
38. Miyasaka K, Takata Y, and Funakoshi A. Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism. J Gastroenterol 37, Suppl 14: 102-106, 2002.
39. Moore KJ and Nagle DL. Complex trait analysis in the mouse: the strengths, the limitations and the promise yet to come. Annu Rev Genet 34: 653-686, 2000.
40. Paigen B, Bouchard G, and Carey MC. Diet-induced Disease: Gallstones, Atherosclerosis, and Plasma Lipids. Bar Harbor, ME: Jackson Laboratory, 2000.
41. Paigen B and Carey MC. Gallstones. In: The Genetic Basis of Common Diseases (2nd ed.), edited by King RA, Rotter JI, and Motulsky AG. New York: Oxford University Press, 2002, p. 298-335.
42. Paigen B, Schork NJ, Svenson KL, Cheah YC, Mu JL, Lammert F, Wang DQH, Bouchard G, and Carey MC. Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice. Physiol Genomics 4: 59-65, 2000. (Corrigenda. Physiol Genomics 4: February 2001, following table of contents)
43. Paigen B, Schork NJ, Svenson KL, Cheah YC, Mu JL, Lammert F, Wang DQH, Bouchard G, and Carey MC. Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice. Physiol Genomics 4: 59-65, 2000. (Corrigenda. Physiol Genomics 4: February 2001, following table of contents)
44. 1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529, 2000.
45. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, and Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology 122: 1500-1511, 2002.
46. Schmitz F, Wang DQH, Blaeker M, Nguyen M, Chiu M, Beinborn M, Carey MC, and Kopin AS. CCK-A receptor deficient mice have an increased susceptibility to cholesterol gallstones (Abstract). Hepatology 24: 246, 1996.
47. Schneider H, Sanger P, and Hanisch E. In vitro effects of cholecystokinin fragments on human gallbladders. Evidence for an altered CCK-receptor structure in a subgroup of patients with gallstones. J Hepatol 26: 1063-1068, 1997.
48. Sen S and Churchill GA. A statistical framework for quantitative trait mapping. Genetics 159: 371-387, 2001.
49. Small DM, Bourgès M, and Dervichian DG. Ternary and quaternary aqueous systems containing bile salt, lecithin, and cholesterol. Nature 211: 816-818, 1966.
50. Takiguchi M. The C/EBP family of transcription factors in the liver and other organs. Int J Exp Pathol 79: 369-391, 1998.
51. Taylor BA, Wnek C, Schroeder D, and Phillips SJ. Multiple obesity QTLs identified in an intercross between the NZO (New Zealand obese) and the SM (small) mouse strains. Mamm Genome 12: 95-103, 2001.
52. Trauner M and Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83: 633-671, 2003; 10.1152/physrev.00027.2002.
53. Wang DQH and Carey MC. Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences. J Lipid Res 37: 2539-2549, 1996.
54. Wang DQH and Carey MC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems. J Lipid Res 37: 606-630, 1996.
55. Wang DQH, Lammert F, Paigen B, and Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice. Pathophysiology of biliary lipid secretion. J Lipid Res 40: 2066-2079, 1999.
56. Wang DQH, Paigen B, and Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 38: 1395-1411, 1997.
57. Wittenburg H, Lammert F, Wang DQH, Churchill GA, Li R, Bouchard G, Carey MC, and Paigen B. Interacting QTLs for cholesterol gallstones and gallbladder mucin in AKR and SWR strains of mice. Physiol Genomics 8: 67-77, 2002. First published December 18, 2001; 10.1152/physiolgenomics.00097.2001.
58. Wittenburg H, Lyons MA, Li R, Churchill GA, Carey MC, and Paigen B. Evidence for FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone susceptibility from a cross of PERA and I mice. Gastroenterology In press.
59. Wittenburg H, Lyons MA, Paigen B, and Carey MC. Mapping cholesterol gallstone susceptibility (Lith) genes in inbred mice. Dig Liver Dis In press.
60. Wittenburg H, Lyons MA, Paigen B, and Carey MC. New cholesterol gallstone susceptibility (Lith) loci with attractive positional candidate genes in an intercross of Pera/Ei and I/LnJ strains of mice (Abstract). Gastroenterology 122: 543, 2002.
61. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, and Hobbs HH. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 99: 16237-16242, 2002.
62. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, and Hobbs HH. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110: 671-680, 2002.
63. Zhu Y, Qi C, Korenberg J, Chen X, Noya D, Rao M, and Reddy J. Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 92: 7921-7925, 1995.